Covance — one of the world's largest and most comprehensive drug development services companies — has the people, global resources and problem-solving culture to respond to pharmaceutical and biotechnology clients' toughest drug development challenges. We provide a portfolio of preclinical and clinical development and commercial service offerings — delivered through industry-leading nonclinical testing services, the world's largest central laboratory network, and a global team of clinical trial professionals and cardiac safety experts.

Our vision is of a sustainable, carbon-neutral world, in which renewable energy and products drive global commerce and industry. Virent will enable the widespread replacement of fossil fuels by economically transforming biomass into universally used fuels and chemicals. Virent Energy has discovered the first practical pathway to widespread freedom from fossil fuels—and is the only energy technology company driving a seismic shift in how biofuels are sourced, produced and transported. Through its patented energy technology—the BioForming™ process—Virent is bringing the reality of a carbon-neutral world one step closer by expanding the roster of usable feedstocks, transforming the conversion process from plant to fuel and enabling a new class of renewable fuels that can move through existing pipelines and power any car, anywhere that gasoline stations exist today.

Headquartered in DeForest, Wisconsin, ABS Global is the world-leading provider of bovine genetics, reproduction services, technologies and uddercare products. Marketing in more than 70 countries around the globe, ABS has been at the forefront of animal genetics and technology since its founding in 1941. ABS Global is part of Genus Breeding, a division of Genus plc.

aOvaTechnologies is a Wisconsin biotechnology company organized in 2001 for the purpose of commercializing a platform of antibody products that improve feed efficiency and growth of animals without the harmful side effects associated with growth promoting antibiotics

eMetagen Corporation is a pharmaceutical discovery company devoted to finding new antibiotics and anticancer drugs. The company has proprietary technologies for cloning very large segments of DNA from soil, giving eMetagen unique access to natural products from uncultivated microorganisms.

ioGenetics LLC designs and produces genetically engineered protein products with applications in food safety and animal health. These include antimicrobial Directed Biocides™.

iMarvel Medtech LLC was organized to develop and commercialize an integrated system for magnetic resonance (MR) imaging-guided interventional (IGI) procedures. The company's MR-IGI system is an enabling platform technology that integrates MR-compatible interactive robotics with state-of-the-art MRI radio frequency receiver coil technology, real-time MR imaging techniques, an interactive planning and control interface and MR-compatible interventional tools for specific diagnostic or therapy applications. The initial target application for this innovative "break-through" technology platform is cryoablation of breast lesions.

Clonex Development, Inc. has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from replicative to production mode (RP Shift™).